GO:0016243 regulation of autophagosome size: Autophagy Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016243 (regulation of autophagosome size) is a biological process that modulates the size of the autophagosome, the double-membrane vesicle that delivers cytoplasmic cargo to lysosomes.
• Autophagosome size is controlled by core autophagy machinery (ATG proteins), membrane sources (ER, COPII vesicles), and signaling pathways such as mTOR.
• Key regulators include ATG9A, SEC31A, PLD1, and SQSTM1/p62, which influence autophagosome expansion and cargo selection.
• Dysregulated autophagosome size is linked to human diseases including Chediak-Higashi syndrome, neurodegeneration, cancer, and ischemia/reperfusion injury.
• Experimental models for studying autophagosome size include CRISPR knockout, point mutation, knock-in, and overexpression cell lines, combined with imaging and omics.
• EDITGENE provides CRISPR services to dissect the causal role of genes in regulating autophagosome size, from KO to library screening.
Description
Autophagy is a conserved catabolic process that sequesters cytoplasmic components into double-membrane vesicles called autophagosomes for lysosomal degradation. The size of these autophagosomes is not fixed; it is dynamically regulated to accommodate cargo of varying dimensions and to meet cellular demands. GO:0016243, regulation of autophagosome size, encompasses any process that modulates the size of the autophagosome. This regulation is critical for efficient cargo clearance and cellular homeostasis, and its disruption contributes to multiple diseases. Understanding how autophagosome size is controlled requires identifying the molecular players and signaling pathways involved. Recent studies have highlighted roles for ER-derived COPII vesicles, phospholipase D1, and selective autophagy receptors in shaping autophagosome dimensions. This article synthesizes current knowledge on GO:0016243, covering its definition, mechanisms, key genes, disease relevance, and research methodologies, with a focus on CRISPR-based approaches for functional dissection.
regulation of autophagosome size At A Glance
| GO ID | GO:0016243 |
|---|---|
| GO term | regulation of autophagosome size |
| Ontology | biological_process |
| Synonym | regulation of autophagic vacuole size |
| Major function | Modulates the dimensions of the autophagosome to accommodate cargo and maintain autophagic flux |
| Related cellular component | Autophagosome, phagophore, COPII vesicles, endoplasmic reticulum |
| Key regulators | ATG9A, SEC31A, PLD1, SQSTM1/p62, mTOR |
| Disease relevance | Chediak-Higashi syndrome, neurodegeneration, cancer, ischemia/reperfusion injury |
What Is GO:0016243?
GO:0016243, regulation of autophagosome size, is defined as any process that modulates the size of the autophagosome. The autophagosome is a double-membrane organelle that forms during autophagy to engulf cytoplasmic cargo. Regulation of its size ensures that vesicles are appropriately dimensioned for the cargo they carry, which can range from small protein aggregates to large organelles. This process involves coordination between membrane supply, lipid composition, and the core autophagy machinery. The synonym 'regulation of autophagic vacuole size' reflects the historical term for autophagosomes.
Why Is regulation of autophagosome size Important in Cell Biology?
Regulation of autophagosome size is fundamental to autophagy efficiency and cellular quality control. Aberrant autophagosome size can impair cargo sequestration and clearance, leading to accumulation of damaged organelles and proteins, which is a hallmark of various pathologies. For example, in Chediak-Higashi syndrome, defects in lysosomal trafficking affect autophagosome maturation. In neurodegeneration, impaired autophagosome dynamics contribute to neuronal toxicity. Thus, understanding GO:0016243 offers insights into disease mechanisms and potential therapeutic targets.
• Ensures efficient sequestration of diverse cargo, from proteins to organelles.
• Impacts autophagic flux and lysosomal degradation capacity.
• Dysregulation is linked to Chediak-Higashi syndrome, a lysosomal trafficking disorder.
• Contributes to neurodegeneration through impaired clearance of aggregated proteins.
• Plays a role in cancer cell survival and drug resistance.
• Modulates ischemia/reperfusion injury in heart and brain.
• Influences oocyte meiosis and spindle assembly.
• Affects adipogenesis and metabolic regulation.
• Provides targets for therapeutic intervention in autophagy-related diseases.
• Requires precise experimental models to dissect gene function.
What Happens During regulation of autophagosome size?
Initiation and Phagophore Expansion
In simple terms: The autophagosome starts as a small membrane sac that grows by adding lipids and proteins.
Autophagosome formation begins with the nucleation of the phagophore, a cup-shaped isolation membrane. The size of the final autophagosome is determined early during phagophore expansion, which requires the delivery of membrane from sources such as the endoplasmic reticulum (ER). COPII vesicles, marked by SEC31A, interact with ATG9A to supply membranes for autophagosome growth. The lipid composition and curvature of the expanding membrane are critical for determining the ultimate size.
Membrane Source Contribution
In simple terms: Membranes from different cellular compartments are delivered to build the autophagosome.
The ER is a major membrane source for autophagosome biogenesis. ER-phagy and ER-derived vesicles contribute to phagophore expansion. Additionally, COPII vesicles mediate the recruitment of membranes to the autophagosome via SEC31A-ATG9A interaction. PLD1, which produces phosphatidic acid, also regulates autophagosome size by influencing membrane dynamics. The coordination of these membrane sources ensures proper autophagosome dimensions.
Cargo Recognition and Sequestration
In simple terms: The autophagosome must be big enough to wrap around the cargo it needs to degrade.
Selective autophagy receptors such as SQSTM1/p62 recognize ubiquitinated cargo and link it to the autophagosome membrane. The size of the autophagosome must accommodate the cargo, which can vary from small protein aggregates to large organelles. In adipogenesis, SQSTM1/p62-mediated selective autophagic degradation of KLF3 is regulated by RPS6KA1 and STAT3 suppression, highlighting how cargo selection influences autophagosome size.
Closure and Maturation
In simple terms: The autophagosome seals and then fuses with lysosomes to degrade its contents.
After expansion, the phagophore closes to form a double-membrane autophagosome. The size of the autophagosome is fixed at closure, and any deviation can affect downstream fusion with lysosomes. Maturation involves fusion with lysosomes to form autolysosomes, where degradation occurs. Defects in closure or maturation can lead to abnormal autophagosome size and impaired flux.
Signaling Regulation of Size
In simple terms: Cellular signals tell the autophagosome how big to grow.
Signaling pathways such as mTOR regulate autophagy initiation and influence autophagosome size. Under nutrient-rich conditions, mTOR inhibits autophagy, while starvation promotes it. Other signals, including SIRT3-mediated mitophagy, can modulate autophagosome size in response to stress. The miR-193a-3p/ALKBH5 pathway has been implicated in autophagy regulation in myocardial ischemia/reperfusion. These signaling inputs fine-tune autophagosome dimensions to match cellular needs.
Key Genes Involved in GO:0016243 regulation of autophagosome size
The following genes and proteins are key players in the regulation of autophagosome size, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG9A | Transmembrane protein that delivers membranes to the phagophore | Essential for autophagosome formation and size regulation |
| SEC31A | COPII coat component that interacts with ATG9A to recruit vesicles | Mediates membrane supply for autophagosome expansion |
| PLD1 | Phospholipase D1 produces phosphatidic acid for membrane dynamics | Regulates autophagosome size in oocyte meiosis |
| SQSTM1/p62 | Selective autophagy receptor for ubiquitinated cargo | Links cargo to autophagosome and influences size |
| MAP1LC3B | Ubiquitin-like protein conjugated to autophagosome membrane | Marker of autophagosomes; used to measure size |
| BECN1 | Part of PI3K complex for autophagosome nucleation | Regulates early steps of autophagosome formation |
| ATG5 | Conjugation system for LC3 lipidation | Required for autophagosome expansion |
| ATG7 | E1-like enzyme for LC3 conjugation | Essential for autophagy and size control |
| ATG16L1 | Part of ATG12-ATG5-ATG16L1 complex | Determines site of LC3 lipidation |
| ULK1 | Serine/threonine kinase that initiates autophagy | Regulates autophagosome size via downstream targets |
| MTOR | Kinase that inhibits autophagy under nutrient-rich conditions | Master regulator of autophagosome size |
| SIRT3 | Mitochondrial deacetylase | Modulates mitophagy and autophagosome size in ischemia |
| RPS6KA1 | Ribosomal S6 kinase | Suppresses STAT3 to regulate SQSTM1/p62-mediated autophagy |
| STAT3 | Transcription factor | Suppresses autophagy and influences autophagosome size |
| KLF3 | Transcription factor degraded by selective autophagy | Cargo for SQSTM1/p62-mediated autophagy |
| ALKBH5 | RNA demethylase | Regulated by miR-193a-3p in autophagy |
| MAP1LC3A | LC3 family member | Autophagosome marker |
| GABARAP | LC3/GABARAP family member | Involved in autophagosome maturation |
How Is regulation of autophagosome size Regulated?
Regulation of autophagosome size is controlled by multiple signaling pathways. The mTOR kinase is a central inhibitor of autophagy; when active under nutrient-rich conditions, it suppresses autophagosome formation, while inhibition by starvation or rapamycin promotes autophagy and can increase autophagosome size. ULK1, a downstream target of mTOR, initiates autophagy and influences phagophore expansion. The PI3K complex containing BECN1 is required for nucleation and affects autophagosome size. Additionally, selective autophagy receptors like SQSTM1/p62 can modulate size based on cargo availability. Other regulators include PLD1, which affects membrane lipid composition, and SIRT3, which modulates mitophagy under stress. The miR-193a-3p/ALKBH5 pathway has been shown to regulate autophagy in myocardial ischemia/reperfusion. These pathways collectively fine-tune autophagosome dimensions to meet cellular demands.
regulation of autophagosome size and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LYST | Chediak-Higashi syndrome | Knockout or point mutation in hematopoietic cell lines |
| SQSTM1/p62 | Neurodegeneration, metabolic disorders | Knockout and overexpression in neuronal or adipocyte models |
| SIRT3 | Ischemia/reperfusion injury | Knockout and overexpression in cardiomyocytes |
| ALKBH5 | Myocardial ischemia/reperfusion | Knockdown and overexpression in cardiac cells |
| PLD1 | Oocyte meiosis | Knockout in mouse oocytes |
Chediak-Higashi Syndrome
Chediak-Higashi syndrome is a rare autosomal recessive disorder characterized by defects in lysosomal trafficking, leading to impaired autophagosome maturation and enlarged lysosomes. Dysregulation of autophagosome size contributes to the accumulation of undegraded cargo, affecting immune and neurological functions. Research into this syndrome has provided insights into the molecular machinery controlling autophagosome dimensions.
Neurodegeneration
In neurodegenerative diseases such as Alzheimer's and Parkinson's, impaired autophagic clearance leads to accumulation of protein aggregates. ER-phagy, a selective form of autophagy, is connected to lysosomal clearance of the endoplasmic reticulum, and its dysregulation affects autophagosome size and neuronal survival. Modulating autophagosome size may offer therapeutic strategies for these conditions.
Cardiovascular Ischemia/Reperfusion Injury
Myocardial ischemia/reperfusion injury involves autophagic dysregulation, where excessive or impaired autophagy contributes to cardiomyocyte death. The Suxiao Jiuxin Pill alleviates injury via the miR-193a-3p/ALKBH5 pathway, affecting autophagy and potentially autophagosome size. Similarly, SIRT3-mediated mitophagy and angiogenesis are targeted by Polyrhachis vicina fraction to protect against cerebral ischemia/reperfusion injury. These studies highlight the therapeutic potential of modulating autophagosome size in cardiovascular and cerebrovascular diseases.
Metabolic Disorders and Adipogenesis
Garcinia cambogia attenuates adipogenesis by affecting CEBPB and SQSTM1/p62-mediated selective autophagic degradation of KLF3 through RPS6KA1 and STAT3 suppression. This indicates that regulation of autophagosome size and selective autophagy play roles in metabolic regulation and obesity. Targeting these pathways could provide new approaches for metabolic disorders.
From regulation of autophagosome size-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate autophagosome size? | CRISPR knockout cell line followed by imaging |
| Does a specific mutation in gene X affect autophagosome size? | Point mutation knock-in cell line |
| How does tagged gene X localize during autophagosome formation? | Knock-in of fluorescent tag (e.g., GFP) |
| Does overexpression of gene X alter autophagosome size? | Overexpression cell line |
| What is the role of gene X in selective autophagy? | Knockout with cargo-specific assays |
| Can gene X rescue autophagosome size defects? | Rescue experiment with wild-type or mutant gene |
How to Study the regulation of autophagosome size Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transmission electron microscopy | Autophagosome size and ultrastructure | Quantification of size in knockout cells |
| Fluorescence microscopy | Number and size of LC3-positive puncta | Live-cell imaging of autophagosome dynamics |
| Western blot | LC3-II levels | Assessment of autophagic flux |
| Immunoprecipitation | Protein-protein interactions | Identifying regulators of autophagosome size |
| CRISPR screen | Genes affecting autophagosome size | High-throughput discovery |
| RNA-seq | Gene expression changes | Transcriptional profiling of autophagy regulators |
| Proteomics | Post-translational modifications | Mapping signaling events |
| Lipidomics | Membrane lipid composition | Linking lipid metabolism to size |
Imaging-Based Quantification
Transmission electron microscopy (TEM) is the gold standard for measuring autophagosome size, providing ultrastructural details. Fluorescence microscopy with GFP-LC3 or mCherry-LC3 allows live-cell imaging of autophagosome number and size. Correlative light and electron microscopy (CLEM) combines the advantages of both. High-content imaging can quantify autophagosome size across thousands of cells.
Biochemical and Molecular Assays
Western blotting for LC3-II levels indicates autophagosome number but not size directly. Immunoprecipitation can identify protein interactions involved in size regulation. Lipidomic analysis can reveal membrane composition changes affecting autophagosome size. Quantitative PCR and RNA-seq can assess expression of autophagy-related genes.
Genetic Screens and Omics
CRISPR knockout library screens can identify genes that regulate autophagosome size when combined with imaging-based readouts. RNA interference (RNAi) screens have also been used. Proteomics can identify post-translational modifications on autophagy proteins. Single-cell RNA-seq can reveal heterogeneity in autophagy gene expression.
Functional Rescue and Validation
Rescue experiments with wild-type or mutant genes in knockout cells validate specific functions. Inducible systems allow temporal control of gene expression to study dynamic changes in autophagosome size. Pharmacological inhibitors or activators (e.g., rapamycin, chloroquine) can modulate autophagy and size. These approaches confirm causality and mechanism.
How CRISPR Can Be Used to Study GO:0016243 regulation of autophagosome size
Knockout
CRISPR knockout (KO) of candidate genes is a powerful approach to determine their role in regulating autophagosome size. By disrupting gene function, researchers can observe changes in autophagosome dimensions using imaging or biochemical assays. For example, KO of ATG9A or SEC31A would impair membrane supply and likely reduce autophagosome size. KO of SQSTM1/p62 would affect selective cargo sequestration and size. EDITGENE provides custom KO cell lines to study these effects.
Point Mutation
Point mutations can mimic disease-associated variants or disrupt specific domains without completely abolishing protein function. For instance, mutating phosphorylation sites in ULK1 or PLD1 can reveal their role in autophagosome size regulation. CRISPR point mutation knock-in allows precise editing of endogenous loci, preserving physiological expression levels. This is crucial for understanding subtle regulatory mechanisms.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) into autophagy genes enables real-time visualization of autophagosome dynamics and size. Tagging ATG9A or LC3 allows tracking of membrane recruitment and autophagosome expansion. Knock-in of disease-relevant mutations (e.g., in LYST for Chediak-Higashi syndrome) can model pathological changes in autophagosome size. EDITGENE offers tagged knock-in services for such studies.
Overexpression
Overexpression of wild-type or mutant genes can reveal gain-of-function effects on autophagosome size. For example, overexpressing PLD1 may increase phosphatidic acid levels and alter membrane curvature, affecting size. Overexpression of SQSTM1/p62 can enhance selective autophagy and potentially enlarge autophagosomes. EDITGENE provides overexpression cell lines to complement KO studies.
How EDITGENE Supports regulation of autophagosome size Research
Researchers studying regulation of autophagosome size-related genes often need to determine whether a candidate gene is causally involved in modulating autophagosome dimensions. This requires precise genetic manipulation and quantitative readouts. EDITGENE offers a comprehensive suite of CRISPR services to facilitate such investigations, from gene knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of autophagosome size research.
Frequently Asked Questions About regulation of autophagosome size
What is GO:0016243?
GO:0016243 is the Gene Ontology term for regulation of autophagosome size, defined as any process that modulates the size of the autophagosome.
What genes are involved in regulation of autophagosome size?
Key genes include ATG9A, SEC31A, PLD1, SQSTM1/p62, ULK1, and MTOR, among others.
How is autophagosome size measured?
Autophagosome size is typically measured by transmission electron microscopy or fluorescence microscopy of LC3-positive structures.
What diseases are linked to autophagosome size dysregulation?
Diseases include Chediak-Higashi syndrome, neurodegeneration, cardiovascular ischemia/reperfusion injury, and metabolic disorders.
What is the role of ATG9A in autophagosome size?
ATG9A delivers membranes to the phagophore and interacts with SEC31A to recruit COPII vesicles, influencing autophagosome expansion and size.
How does mTOR regulate autophagosome size?
mTOR inhibits autophagy under nutrient-rich conditions; its inhibition promotes autophagosome formation and can affect size.
Can CRISPR be used to study autophagosome size?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in autophagosome size regulation.
What is the relationship between SQSTM1/p62 and autophagosome size?
SQSTM1/p62 is a selective autophagy receptor that links cargo to the autophagosome; its activity can influence autophagosome size based on cargo load.
How does PLD1 affect autophagosome size?
PLD1 produces phosphatidic acid, which alters membrane lipid composition and dynamics, thereby regulating autophagosome size.
What experimental models are available for studying regulation of autophagosome size?
Models include CRISPR knockout cell lines, point mutation knock-ins, tagged knock-ins, overexpression lines, and library screens, often combined with imaging and omics.
Conclusion
Regulation of autophagosome size (GO:0016243) is a critical aspect of autophagy that ensures efficient cargo sequestration and cellular homeostasis. Dysregulation of this process contributes to a range of human diseases, from lysosomal storage disorders to neurodegeneration and cardiovascular injury. Advances in CRISPR-based genetic models and imaging technologies are enabling precise dissection of the molecular mechanisms controlling autophagosome dimensions. EDITGENE's comprehensive services support researchers in uncovering new regulators and therapeutic targets within this pathway.
References
- 1. Talbert ML et al.. 2023. Chediak-Higashi syndrome.. Curr Opin Hematol 30(4):144-151 PMID: 37254856
- 2. Reggiori F et al.. 2022. ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum.. Physiol Rev 102(3):1393-1448 PMID: 35188422
- 3. Wang D et al.. 2024. Suxiao Jiuxin Pill alleviates myocardial ischemia/reperfusion-induced autophagy via miR-193a-3p/ALKBH5 pathway.. Phytomedicine 125:155359 PMID: 38301300
- 4. Jin M et al.. 2014. Regulation of autophagy: modulation of the size and number of autophagosomes.. FEBS Lett 588(15):2457-63 PMID: 24928445
- 5. Zhang J et al.. 2024. PLD1 promotes spindle assembly and migration through regulating autophagy in mouse oocyte meiosis.. Autophagy 20(7):1616-1638 PMID: 38513669
- 6. Nie J et al.. 2024. SEC31a-ATG9a Interaction Mediates the Recruitment of COPII Vesicles for Autophagosome Formation.. Adv Sci (Weinh) 11(44):e2405127 PMID: 39361436
- 7. Wei J et al.. 2023. Active fraction of Polyrhachis vicina (Roger) alleviated cerebral ischemia/reperfusion injury by targeting SIRT3-mediated mitophagy and angiogenesis.. Phytomedicine 121:155104 PMID: 37797433
- 8. Han JH et al.. 2022. Garcinia cambogia attenuates adipogenesis by affecting CEBPB and SQSTM1/p62-mediated selective autophagic degradation of KLF3 through RPS6KA1 and STAT3 suppression.. Autophagy 18(3):518-539 PMID: 34101546
